Biomedical Engineering Reference
In-Depth Information
17. Chen, C.,
et al.
, An in vitro study of liposomal curcumin: stability, toxicity
and biological activity in human lymphocytes and Epstein-Barr virus-trans-
formed human B-cells.
Int J Pharm
, 2009. 366(1-2): p. 133-9.
18. Orr, W.S.,
et al.
, Liposome-encapsulated curcumin suppresses neuroblas-
toma growth through nuclear factor-kappa B inhibition.
Surgery
, 2012.
151(5): p. 736-44.
19. Wang, D.,
et al.
, Liposome-encapsulated curcumin suppresses growth of
head and neck squamous cell carcinoma in vitro and in xenograt s through
the inhibition of nuclear factor kappaB by an AKT-independent pathway.
Clin Cancer Res
, 2008. 14(19): p. 6228-36.
20. Li, S.,
et al.
, In-vitro and in-vivo evaluation of austocystin D liposomes.
J
Pharm Pharmacol
, 2013. 65(3): p. 355-62.
21. O'Brien, S.,
et al.
, High-dose vincristine sulfate liposome injection for
advanced, relapsed, and refractory adult Philadelphia chromosome-negative
acute lymphoblastic leukemia.
J Clin Oncol
, 2013. 31(6): p. 676-83.
22. Gupta, V.,
et al.
, Liposomal fasudil, a rho-kinase inhibitor, for prolonged
pulmonary preferential vasodilation in pulmonary arterial hypertension.
J
Control Release
, 2013. 167(2): p. 189-99.
23. Chithrani, D.B.,
et al.
, Cellular uptake and transport of gold nanoparticles
incorporated in a liposomal carrier.
Nanomedicine
, 2010. 6(1): p. 161-9.
24. Sandhya, K.V., G.S. Devi, and S.T. Mathew, Liposomal formulations of serra-
tiopeptidase: In vitro studies using PAMPA and caco-2 models.
Mol Pharm
,
2008. 5(1): p. 92-97.
25. Zeevalk, G.D., L.P. Bernard, and F.T. Guilford, Liposomal-glutathione pro-
vides maintenance of intracellular glutathione and neuroprotection in mes-
encephalic neuronal cells.
Neurochem Res
, 2010. 35(10): p. 1575-87.
26. Alves, J.B.,
et al.
, Local delivery of EGF-liposome mediated bone modeling
in orthodontic tooth movement by increasing RANKL expression.
Life Sci
,
2009. 85(19-20): p. 693-9.
27. Bhansali, S.G., S.V. Balu-Iyer, and M.E. Morris, Inl uence of route of admin-
istration and liposomal encapsulation on blood and lymph node exposure to
the protein VEGF-C156S.
J Pharm Sci
, 2012. 101(2): p. 852-9.
28. Dvoriantchikova, G.,
et al.
, Liposome-delivered ATP ef ectively pro-
tects the retina against ischemia-reperfusion injury.
Mol Vis
, 2010. 16:
p. 2882-90.
29. Martinez-Lostao, L.,
et al.
, Liposome-bound APO2L/TRAIL is an ef ective
treatment in a rabbit model of rheumatoid arthritis.
Arthritis Rheum
, 2010.
62(8): p. 2272-82.
30. Villares, G.J.,
et al.
, Targeting melanoma growth and metastasis with sys-
temic delivery of liposome-incorporated protease-activated receptor-1 small
interfering RNA.
Cancer Res
, 2008. 68(21): p. 9078-86.
31. Hak, S.,
et al.
, A high relaxivity Gd(III)DOTA-DSPE-based liposomal con-
trast agent for magnetic resonance imaging.
Eur J Pharm Biopharm
, 2009.
72(2): p. 397-404.
